Padmanee Sharma

5 ta ish

The University of Texas MD Anderson Cancer Center

1. Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients

   Vancheswaran Gopalakrishnan, C. N. Spencer, Luigi Nezi +67

   Maqola20177 iqtibos

   ABIABI:AkademIndex/2026.other.339918

2. Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy

   Padmanee Sharma, Siwen Hu‐Lieskovan, Jennifer A. Wargo +1

   Sharh maqola20174 iqtibos

   ABIABI:AkademIndex/2026.other.748211

3. The future of immune checkpoint therapy

   Padmanee Sharma, James P. Allison

   Sharh maqola20152 iqtibos

   ABIABI:AkademIndex/2026.other.082751

4. Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response

   Christine N. Spencer, Jennifer L. McQuade, Vancheswaran Gopalakrishnan +86

   Maqola20212 iqtibos

   ABIABI:AkademIndex/2026.other.468922

5. Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma

   Robert J. Motzer, Bernard Escudier, Ray McDermott +24

   Maqola20152 iqtibos

   ABIABI:AkademIndex/2026.other.679071